The Swiss Biotech Day on 8 April 2014 is the leading biotechnology conference in Switzerland. Every year, this event brings together more than 200 senior executives from the life science industry across Europe. For a face to face meeting to learn more about Dualsystems and its new technology to identify receptors of your ligand on…
This author has yet to write their bio.Meanwhile lets just say that we are proud helene contributed a whooping 55 entries.
Entries by helene
Video interview of CaptiRec Services, ligand-receptor capture technology (LRC) with Dr. Paul Helbling, the new management of Dualsystems Biotech AG.
Dualsystems Biotech has closed a Series C financing round with support from existing and new investors to implement and drive forward its new business strategy in mass spectrometry based protein interaction discovery.
Dualsystems Biotech is driving its business activities towards new technologies and builds up new strengths in the field of protein interaction discovery.
Dualsystems Biotech closes Licensing Agreement with ETH Zurich on Ligand Receptor Capture (LRC) technology Dualsystems Biotech has licensed an innovative technology to discover cell-surface receptors for a vast range of ligands of interest. LRC is centered around an innovative trifunctional chemoproteomic reagent named TriCEPS™, which enables the unbiased identification of cell surface receptors for many…
Dualsystems Biotech AG
Dr. Paul Helbling
phone +41 44 738 50 00
fax +41 44 738 50 05
LRC-TriCEPS explained in a short video